These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 2782977)
1. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Kyle V; Cawston TE; Hazleman BL Ann Rheum Dis; 1989 Aug; 48(8):667-71. PubMed ID: 2782977 [TBL] [Abstract][Full Text] [Related]
2. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis. Pountain GD; Calvin J; Hazleman BL Br J Rheumatol; 1994 Jun; 33(6):550-4. PubMed ID: 8205403 [TBL] [Abstract][Full Text] [Related]
3. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis. Park JR; Jones JG; Hazleman BL Ann Rheum Dis; 1981 Oct; 40(5):493-5. PubMed ID: 6171213 [TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations. Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765 [TBL] [Abstract][Full Text] [Related]
5. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. Kyle V; Hazleman BL Ann Rheum Dis; 1989 Aug; 48(8):658-61. PubMed ID: 2782975 [TBL] [Abstract][Full Text] [Related]
6. Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease. Hachulla E; Saile R; Parra HJ; Hatron PY; Gosset D; Fruchart JC; Devulder B Clin Exp Rheumatol; 1991; 9(2):157-63. PubMed ID: 1711943 [TBL] [Abstract][Full Text] [Related]
7. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Kermani TA; Schmidt J; Crowson CS; Ytterberg SR; Hunder GG; Matteson EL; Warrington KJ Semin Arthritis Rheum; 2012 Jun; 41(6):866-71. PubMed ID: 22119103 [TBL] [Abstract][Full Text] [Related]
8. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209 [TBL] [Abstract][Full Text] [Related]
9. The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome. Ellis ME; Ralston S Ann Rheum Dis; 1983 Apr; 42(2):168-70. PubMed ID: 6847261 [TBL] [Abstract][Full Text] [Related]
10. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis. Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589 [TBL] [Abstract][Full Text] [Related]
11. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review. Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026 [TBL] [Abstract][Full Text] [Related]
12. Giant cell arteritis with an erythrocyte sedimentation rate lower than 50. Martínez-Taboada VM; Blanco R; Armona J; Uriarte E; Figueroa M; Gonzalez-Gay MA; Rodriguez-Valverde V Clin Rheumatol; 2000; 19(1):73-5. PubMed ID: 10752506 [TBL] [Abstract][Full Text] [Related]
13. CD8+ lymphocyte subset in polymyalgia rheumatica and arteritis temporalis. Inverse relationship between the acute hepatic phase reactants and the CD8+ T-cell subset. Elling H; Elling P; Olsson A Clin Exp Rheumatol; 1989; 7(6):627-30. PubMed ID: 2533002 [TBL] [Abstract][Full Text] [Related]
14. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data. Pamuk ON; Dönmez S; Karahan B; Pamuk GE; Cakir N Clin Exp Rheumatol; 2009; 27(5):830-3. PubMed ID: 19917168 [TBL] [Abstract][Full Text] [Related]
15. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica. van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206 [TBL] [Abstract][Full Text] [Related]
16. Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis. Garcia-Unzueta MT; Martínez-Taboada VM; Amado-Señarís JA; Rodríguez-Valverde V Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S6-9. PubMed ID: 16859588 [TBL] [Abstract][Full Text] [Related]
17. Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study. Mallya RK; Hind CR; Berry H; Pepys MB Arthritis Rheum; 1985 Apr; 28(4):383-7. PubMed ID: 2859021 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic difficulties in polymyalgia rheumatica cases with normal erythrocyte sedimentation rate and C-reactive protein values. Kara M; Alp G; Koç AM Medicine (Baltimore); 2023 Sep; 102(39):e35385. PubMed ID: 37773830 [TBL] [Abstract][Full Text] [Related]
19. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica. van Sleen Y; Graver JC; Abdulahad WH; van der Geest KSM; Boots AMH; Sandovici M; Brouwer E Front Immunol; 2019; 10():1981. PubMed ID: 31507597 [TBL] [Abstract][Full Text] [Related]
20. [C-reactive protein or blood sedimentation reaction os preventive studies in the physician's laboratory?]. Steiner A; Vetter W Ther Umsch; 1995 May; 52(5):350-4. PubMed ID: 7770822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]